Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Lymphoma 145Precursor Cell Lymphoblastic Leukemia-Lymphoma 110Lymphoma, Large B-Cell, Diffuse 89Leukemia 74Lymphoma, Non-Hodgkin 60Lymphoma, Follicular 47Burkitt Lymphoma 45Lymphoma, Mantle-Cell 43Hodgkin Disease 31Neuroblastoma 30Central Nervous System Neoplasms 29Sarcoma 24Lymphoma, Large-Cell, Immunoblastic 23Lymphoma, Large-Cell, Anaplastic 21Multiple Myeloma 19Leukemia, Lymphocytic, Chronic, B-Cell 16Lymphoma, B-Cell, Marginal Zone 15HIV Infections 15Brain Neoplasms 15Medulloblastoma 11Dendritic Cell Sarcoma, Interdigitating 11Astrocytoma 11Acquired Immunodeficiency Syndrome 11Rhabdomyosarcoma 10Lymphoma, T-Cell, Peripheral 10Lymphoma, B-Cell 10Recurrence 9Oligodendroglioma 9Neuroectodermal Tumors, Primitive, Peripheral 9Neoplasms 9

Interventions

Vincristine 2Oncolytic Virotherapy 2pralsetinib 1pembrolizumab 1pamiparib 1interferon gamma-1b 1cixutumumab 1Valproic Acid 1Radiotherapy 1Radiation 1Maintenance Chemotherapy 1Lomustine 1Interferon-gamma 1Immunotherapy 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1Antibodies, Monoclonal 1Afatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neuroectodermal Tumors × Vincristine × Clear all
NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed
33 enrolled
CNS

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

NCT00001209 2008-03-04

A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
120 enrolled
Sarcoma

Sarcoma, Sarcoma, Ewing, Osteosarcoma, Neuroectodermal Tumors, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡